Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 8427866)

Published in Arterioscler Thromb on February 01, 1993

Authors

C M Gibson1, L Diaz, K Kandarpa, F M Sacks, R C Pasternak, T Sandor, C Feldman, P H Stone

Author Affiliations

1: Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Articles citing this

Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev (2011) 5.51

Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest (1995) 1.71

Cataloguing the geometry of the human coronary arteries: a potential tool for predicting risk of coronary artery disease. Int J Cardiol (2008) 1.55

Intravascular imaging of vulnerable coronary plaque: current and future concepts. Nat Rev Cardiol (2011) 1.35

Validation of CFD simulations of cerebral aneurysms with implication of geometric variations. J Biomech Eng (2006) 1.15

Plaque development, vessel curvature, and wall shear stress in coronary arteries assessed by X-ray angiography and intravascular ultrasound. Med Image Anal (2006) 1.04

Advanced human carotid plaque progression correlates positively with flow shear stress using follow-up scan data: an in vivo MRI multi-patient 3D FSI study. J Biomech (2010) 1.04

Image-based modeling for better understanding and assessment of atherosclerotic plaque progression and vulnerability: data, modeling, validation, uncertainty and predictions. J Biomech (2014) 1.02

Coronary artery flow measurement using navigator echo gated phase contrast magnetic resonance velocity mapping at 3.0 T. J Biomech (2007) 0.99

Coronary artery plaque formation at coronary CT angiography: morphological analysis and relationship to hemodynamics. Eur Radiol (2008) 0.93

Nrf2 and cardiovascular defense. Oxid Med Cell Longev (2013) 0.91

Computer-Aided Patient-Specific Coronary Artery Graft Design Improvements Using CFD Coupled Shape Optimizer. Cardiovasc Eng Technol (2010) 0.87

Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension. Am J Physiol Cell Physiol (2014) 0.85

Computer simulations of atherosclerotic plaque growth in coronary arteries. Mol Cell Biomech (2010) 0.85

Role of oxidative stress in adaptive responses in special reference to atherogenesis. J Clin Biochem Nutr (2008) 0.84

The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence. Angiogenesis (2015) 0.83

Correlations between carotid plaque progression and mechanical stresses change sign over time: a patient follow up study using MRI and 3D FSI models. Biomed Eng Online (2013) 0.82

Impact of flow rates in a cardiac cycle on correlations between advanced human carotid plaque progression and mechanical flow shear stress and plaque wall stress. Biomed Eng Online (2011) 0.82

Correlations of coronary plaque wall thickness with wall pressure and wall pressure gradient: a representative case study. Biomed Eng Online (2012) 0.79

IVUS-based computational modeling and planar biaxial artery material properties for human coronary plaque vulnerability assessment. Mol Cell Biomech (2012) 0.79

Influence of non-Newtonian properties of blood on the wall shear stress in human atherosclerotic right coronary arteries. Mol Cell Biomech (2011) 0.79

Association of Early Atherosclerosis with Vascular Wall Shear Stress in Hypercholesterolemic Zebrafish. PLoS One (2015) 0.79

Acetylcholine released by endothelial cells facilitates flow-mediated dilatation. J Physiol (2016) 0.78

Three-Dimensional Carotid Plaque Progression Simulation Using Meshless Generalized Finite Difference Method Based on Multi-Year MRI Patient-Tracking Data. Comput Model Eng Sci (2010) 0.78

Numerical investigation of blood flow in a deformable coronary bifurcation and non-planar branch. Bioimpacts (2014) 0.77

Hemodynamic analysis in an idealized artery tree: differences in wall shear stress between Newtonian and non-Newtonian blood models. PLoS One (2015) 0.77

Quantification and comparison of 4D-flow MRI-derived wall shear stress and MRE-derived wall stiffness of the abdominal aorta. J Magn Reson Imaging (2016) 0.76

Patient-Specific Carotid Plaque Progression Simulation Using 3D Meshless Generalized Finite Difference Models with Fluid-Structure Interactions Based on Serial In Vivo MRI Data. Comput Model Eng Sci (2011) 0.75

Influences of Geometric Configurations of Bypass Grafts on Hemodynamics in End-to-Side Anastomosis. Korean J Thorac Cardiovasc Surg (2011) 0.75

Articles by these authors

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology (1997) 7.81

Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol (2000) 6.40

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13

Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12

Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09

Circadian variation and triggers of onset of acute cardiovascular disease. Circulation (1989) 4.48

Circadian variation in the frequency of sudden cardiac death. Circulation (1987) 3.98

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69

Unstable angina pectoris. N Engl J Med (2000) 3.58

Depression, heart rate variability, and acute myocardial infarction. Circulation (2001) 3.57

Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19

Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation (1998) 2.97

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.80

Pulmonary echinococcosis. Eur Respir J (2003) 2.80

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (2001) 2.79

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77

A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest (1989) 2.76

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68

Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68

Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68

Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37

The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med (2000) 2.34

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30

Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol (1987) 2.27

The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med (1980) 2.19

Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol (1983) 2.18

Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18

Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol (1993) 2.17

Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology (1990) 2.14

Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med (1992) 2.11

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med (1980) 2.08

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med (1996) 2.03

Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol (1987) 2.01

Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med (1986) 1.96

White matter changes with normal aging. Neurology (1998) 1.95

Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92

Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab (1997) 1.88

Cardiovascular disease in women. Circulation (1993) 1.87

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87

The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78

Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77

Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. Circulation (1996) 1.76

Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75

A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74

Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J (1988) 1.69

Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol (1990) 1.68

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67

Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS) Circulation (1993) 1.66

First steps toward understanding the pathophysiologic link between air pollution and cardiac mortality. Am Heart J (1999) 1.65

Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun (1989) 1.64

Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation (1998) 1.64

Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). Am J Cardiol (1993) 1.63

Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis (2001) 1.62

Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J (1989) 1.62

Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Curr Opin Cardiol (2000) 1.60

Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol (1985) 1.60

Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59

ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol (1999) 1.59

Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58

Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57

Ambient particulate air pollution and cardiac arrhythmia in a panel of older adults in Steubenville, Ohio. Occup Environ Med (2006) 1.56

Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation (1996) 1.55

Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med (1985) 1.54

Climate change. Uncertainty and climate change assessments. Science (2001) 1.54

A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial). Eur Heart J (2000) 1.51

Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50

A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol (1986) 1.50

Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1997) 1.49

Patterns of cytokine expression in community-acquired pneumonia. Chest (1995) 1.46

Guideline for the management of acute asthma in adults: 2013 update. S Afr Med J (2012) 1.46

Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. Am J Cardiol (1989) 1.44

Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol (1994) 1.43

High-density lipoprotein subfractions. Am J Med (1993) 1.42

Differentiation of sarcoidosis from tuberculosis using an enzyme-linked immunosorbent assay for the detection of antibodies against Mycobacterium tuberculosis. Chest (1988) 1.42

Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol (1997) 1.42

Problems on the pathway from risk assessment to risk reduction. Circulation (1998) 1.41

Determination of blood flow and endothelial shear stress in human coronary artery in vivo. J Invasive Cardiol (1999) 1.41

Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol (1991) 1.41

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation (1984) 1.41

The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40

Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J (1989) 1.40

Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40

Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. Eur Respir J (2006) 1.40

Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol (1995) 1.39

Enzyme-linked immunosorbent assay for the detection of antibodies against Mycobacterium tuberculosis in bronchial washings and serum. Chest (1988) 1.39

The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39

Abdominal findings in AIDS-related pulmonary tuberculosis correlated with associated CD4 levels. Abdom Imaging (1999) 1.38

Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med (1993) 1.38